静脉-静脉体外膜氧合脱机准备每日评估方案的安全性与可行性
方案包括安全筛查、非ECMO下FiO2滴定和无ECMO试验三阶段,共385个患者日。结果显示无遗漏筛查、方案偏差或不良事件,16例通过无ECMO试验的患者中14例(87.5%)成功拔管。
要点
- 每日脱机准备评估方案在VV-ECMO患者中可行且安全,无方案偏差或不良事件。
- 通过无ECMO试验的患者中87.5%成功拔管,首次通过至拔管中位时间2天。
- 该方案可能比逐渐撤机方法更早识别适合拔管的患者。
核心结论
- 每日脱机准备评估方案在VV-ECMO患者中可行且安全,可能比逐渐撤机方法更早识别适合拔管的患者。
主要发现
- 无遗漏安全筛查、方案偏差或不良事件发生。
- 16例通过无ECMO试验的患者中14例(87.5%)拔管,其中12例(85.7%)在通过试验当天拔管,6例(42.9%)在首次通过试验当天拔管,6例(42.9%)在拔管前至少连续两次通过试验。
- 从首次通过无ECMO试验至拔管的中位时间为2天(四分位距0-3天)。
临床怎么用
- 该方案可作为VV-ECMO患者每日脱机准备评估的可行工具,帮助临床团队安全地早期识别拔管候选者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decannulation from venovenous extracorporeal membrane oxygenation (ECMO) at the earliest and safest possible time may improve outcomes and reduce cost. Yet, no prospective studies have compared weaning strategies for liberation from ECMO. RESEARCH QUESTION: Is a protocolized daily assessment of readiness to liberate from venovenous ECMO safe and feasible? STUDY DESIGN AND METHODS: We conducted a prospective, single-arm safety and feasibility study of a protocol for daily assessment of readiness to liberate from venovenous ECMO among consecutive adult patients receiving venovenous ECMO across four ICUs at a single center between June 20, 2020, and November 24, 2020. The ECMO-free protocol included three phases: (1) the safety screening, (2) non-ECMO Fio2 titration, and (3) the ECMO-free trial. Enrollment, interventions, and data collection were performed prospectively by trained study staff. RESULTS: Twenty-six patients received the ECMO-free protocol on 385 patient-days. The safety screening was passed during a total of 59 ECMO-free daily assessments (15.3%) among 20 patients. Every passed safety screening proceeded to an ECMO-free trial. Twenty-eight passed ECMO-free trials (47.5%) occurred among 16 patients (61.5%). No missed safety screenings, protocol deviations, or adverse events occurred. Of the 16 patients who passed an ECMO-free trial, 14 patients (87.5%) were decannulated. Among decannulated patients, 12 patients (85.7%) were decannulated on the same day as a passed ECMO-free trial, 6 patients (42.9%) were decannulated on the first day that they passed an ECMO-free trial, and 6 patients (42.9%) passed an ECMO-free trial at least twice consecutively before decannulation. The median time from first passed ECMO-free trial to decannulation was 2 days (interquartile range, 0-3 days). INTERPRETATION: The ECMO-free protocol is feasible and may identify patients for decannulation earlier than gradual approaches to weaning.
引用
- Gannon WD, Stokes JW, Bloom S, et al. Safety and Feasibility of a Protocolized Daily Assessment of Readiness for Liberation From Venovenous Extracorporeal Membrane Oxygenation. Chest. 2021. PMID: 34166644. doi:10.1016/j.chest.2021.05.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。